Prognostic factors and outcomes of COVID-19 cases in Ethiopia: multi-center cohort study protocol.
COVID-19
Cohort
Ethiopia
Outcomes of COVID
Prognostic Factors
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
16 Sep 2021
16 Sep 2021
Historique:
received:
25
12
2020
accepted:
01
09
2021
entrez:
17
9
2021
pubmed:
18
9
2021
medline:
25
9
2021
Statut:
epublish
Résumé
The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) and became pandemic after emerging in Wuhan, China, in December 2019. Several studies have been conducted to understand the key features of COVID-19 and its public health impact. However, the prognostic factors of COVID-19 are not well studied in the African setting. In this study, we aim to determine the epidemiological and clinical features of COVID-19 cases, immunological and virological courses, interaction with nutritional status, and response to treatment for COVID-19 patients in Ethiopia. A multi-center cohort study design will be performed. Patients with confirmed COVID-19 infection admitted to selected treatment centers will be enrolled irrespective of their symptoms and followed-up for 12 months. Baseline epidemiological, clinical, laboratory and imaging data will be collected from treatment records, interviews, physical measurements, and biological samples. Follow-up data collection involves treatment and prognostic outcomes to be measured using different biomarkers and clinical parameters. Data collection will be done electronically using the Open Data Kit (ODK) software package and then exported to STATA/SPSS for analysis. Both descriptive and multivariable analyses will be performed to assess the independent determinants of the treatment outcome and prognosis to generate relevant information for informed prevention and case management. The primary outcomes of this study are death/survival and viral shedding. Secondary outcomes include epidemiological characteristics, clinical features, genetic frequency shifts (genotypic variations), and nutritional status. This is the first large prospective cohort study of patients in hospitals with COVID-19 in Ethiopia. The results will enable us to better understand the epidemiology of SARS-CoV-2 in Africa. This study will also provide useful information for effective public health measures and future pandemic preparedness and in response to outbreaks. It will also support policymakers in managing the epidemic based on scientific evidence. The Protocol prospectively registered in ClinicalTrials.gov (NCT04584424) on 30 October, 2020.
Sections du résumé
BACKGROUND
BACKGROUND
The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) and became pandemic after emerging in Wuhan, China, in December 2019. Several studies have been conducted to understand the key features of COVID-19 and its public health impact. However, the prognostic factors of COVID-19 are not well studied in the African setting. In this study, we aim to determine the epidemiological and clinical features of COVID-19 cases, immunological and virological courses, interaction with nutritional status, and response to treatment for COVID-19 patients in Ethiopia.
METHODS
METHODS
A multi-center cohort study design will be performed. Patients with confirmed COVID-19 infection admitted to selected treatment centers will be enrolled irrespective of their symptoms and followed-up for 12 months. Baseline epidemiological, clinical, laboratory and imaging data will be collected from treatment records, interviews, physical measurements, and biological samples. Follow-up data collection involves treatment and prognostic outcomes to be measured using different biomarkers and clinical parameters. Data collection will be done electronically using the Open Data Kit (ODK) software package and then exported to STATA/SPSS for analysis. Both descriptive and multivariable analyses will be performed to assess the independent determinants of the treatment outcome and prognosis to generate relevant information for informed prevention and case management. The primary outcomes of this study are death/survival and viral shedding. Secondary outcomes include epidemiological characteristics, clinical features, genetic frequency shifts (genotypic variations), and nutritional status.
DISCUSSION
CONCLUSIONS
This is the first large prospective cohort study of patients in hospitals with COVID-19 in Ethiopia. The results will enable us to better understand the epidemiology of SARS-CoV-2 in Africa. This study will also provide useful information for effective public health measures and future pandemic preparedness and in response to outbreaks. It will also support policymakers in managing the epidemic based on scientific evidence.
TRIAL REGISTRATION
BACKGROUND
The Protocol prospectively registered in ClinicalTrials.gov (NCT04584424) on 30 October, 2020.
Identifiants
pubmed: 34530744
doi: 10.1186/s12879-021-06652-0
pii: 10.1186/s12879-021-06652-0
pmc: PMC8443913
doi:
Banques de données
ClinicalTrials.gov
['NCT04584424']
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
956Informations de copyright
© 2021. The Author(s).
Références
Science. 2020 May 8;368(6491):638-642
pubmed: 32234804
Nat Commun. 2019 Apr 3;10(1):1507
pubmed: 30944315
Acta Paediatr. 2020 Jun;109(6):1088-1095
pubmed: 32202343
Clin Infect Dis. 2011 Feb 1;52(3):301-12
pubmed: 21208911
BMJ. 2020 Jun 8;369:m2107
pubmed: 32513659
Influenza Other Respir Viruses. 2019 Jan;13(1):3-9
pubmed: 30515985
JAMA. 2004 Sep 15;292(11):1333-40
pubmed: 15367555
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
Environ Sci Pollut Res Int. 2020 Nov;27(33):42115-42123
pubmed: 32710359
Nutrients. 2020 Apr 02;12(4):
pubmed: 32252338
Acta Obstet Gynecol Scand. 2020 Jul;99(7):823-829
pubmed: 32259279
Circulation. 1999 Jul 27;100(4):354-60
pubmed: 10421594
Int J Surg. 2020 Jun;78:185-193
pubmed: 32305533
J Pathol. 2015 Jan;235(2):175-84
pubmed: 25294366
Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4440-5
pubmed: 27036003
N Engl J Med. 2020 Apr 23;382(17):1663-1665
pubmed: 32187458
Lancet Psychiatry. 2020 Sep;7(9):813-824
pubmed: 32682460
J Am Coll Cardiol. 2020 May 12;75(18):2352-2371
pubmed: 32201335
JAMA Intern Med. 2020 Apr 1;180(4):605-606
pubmed: 32150227
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14304-7
pubmed: 8962043
Ned Tijdschr Geneeskd. 2001 Jun 30;145(26):1261-5
pubmed: 11455695
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):779-788
pubmed: 32526627